ID: ALA104897

Max Phase: Preclinical

Molecular Formula: C5H14N+

Molecular Weight: 88.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[N+](C)(C)C

Standard InChI:  InChI=1S/C5H14N/c1-5-6(2,3)4/h5H2,1-4H3/q+1

Standard InChI Key:  YOMFVLRTMZWACQ-UHFFFAOYSA-N

Associated Targets(non-human)

Creatine transporter 104 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 88.17Molecular Weight (Monoisotopic): 88.1121AlogP: 0.71#Rotatable Bonds: 1
Polar Surface Area: 0.00Molecular Species: HBA: 0HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -3.62CX LogD: -3.62
Aromatic Rings: 0Heavy Atoms: 6QED Weighted: 0.41Np Likeness Score: 0.35

References

1. Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD..  (2004)  Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.,  14  (12): [PMID:15149650] [10.1016/j.bmcl.2004.04.020]

Source